Items Tagged ‘General Myelodysplastic Syndrome’

August 31st, 2016

Revlimid® Reduces Need for Blood Transfusions in Some Myelodysplastic Syndromes

By

The agent Revlimid (lenalidomide) reduces the need for blood transfusions among patients with lower-risk, non-del (5q) myelodysplastic syndromes who are dependent upon red blood cell transfusions, but are not eligible for erythropoiesis-stimulating agents. These results were recently published in the Journal of Clinical Oncology. Myelodysplastic syndromes (MDS) refer to a group of diseases in which […]

View full entry

Tags: clinical trial, General Myelodysplastic Syndrome, lenalidomide, MDS, Myelodysplastic Syndrome, News, RBC, revlimid


December 30th, 2015

Myeloablative Treatment Regimens Superior to Reduced Intensity Treatment for AML and MDS Patients Undergoing Stem Cell Transplant

By

Hematopoietic Stem Cell Transplant (SCT) is a standard and potentially curative treatment for individuals with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Historically only high dose myeloablative treatment regimens were utilized since they were thought necessary to eradicate the malignant cells in the bone marrow. In recent years, SCT physicians have increasingly used reduced […]

View full entry

Tags: Acute Myeloid Leukemia, Allogeneic Stem Cell Transplant, AML, General Myelodysplastic Syndrome, hematopoietic stem cell transplant, Leukemia, MDS, Myelodysplastic Syndrome, News, sct, Stem Cell Transplant


August 8th, 2014

Exposure to Some Inflammatory Bowel Disease Drugs May Increase Leukemia Risk

By

Thiopurines are an established treatment for inflammatory bowel disease (IBD) patients.  They are used to reduce inflammation and provide symptom relief.  Thiopurine immunosuppressive drugs have now been reported to increase the risk of acute myelod leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among IBD patients. These data were recently reported in a […]

View full entry

Tags: Acute Myeloid Leukemia, AML, cancer prevention, General Myelodysplastic Syndrome, Health and Wellness, Leukemia, MDS, Myelodysplastic Syndrome, News, Screening/Prevention Leukemia, thiopurines


March 26th, 2012

Aspirin Continues to Look Promising for Cancer Prevention

By

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce the risk of several types of cancer, with particularly strong evidence […]

View full entry

Tags: Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, General Bone Cancer, General Brain Cancer, General Head and Neck Cancer


July 15th, 2011

Stay on Top of Your Family History of Cancer

By

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically with your healthcare provider. This was the conclusion of a study published in […]

View full entry

Tags: All Cancer Types, Anal Cancer, Bladder Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Stromal Tumors, General Bone Cancer


May 13th, 2011

Regular Use of Acetaminophen May Increase Risk of Blood Cancers

By

Long-term, regular use of acetaminophen (Tylenol®) may increase the risk of leukemia and lymphoma. These results were published in the Journal of Clinical Oncology. Some studies have suggested that use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen may reduce the risk of colorectal cancer and certain other types of cancer. Acetaminophen—another […]

View full entry

Tags: General Myelodysplastic Syndrome, Leukemia, Myelodysplastic Syndrome, News, Non-Hodgkin's Lymphoma, Screening/Prevention Leukemia, Screening/Prevention Non-Hodgkin's Lymphoma


January 21st, 2008

Supportive Care and Hematologic Malignancies

By

Supportive Care and Hematologic Malignancies: A Report from the 2007 American Society of Hematology (ASH) Meeting Introduction At the 2007 meeting of the American Society of Hematology (ASH) the most interesting supportive care studies involved second generation thrombopoetin-like agents that should ultimately improve the treatment of thrombocytopenia. Thrombocytopenia Thrombocytopenia is a major cause of morbidity […]

View full entry

Tags: Aggressive/Intermediate Grade Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia, General Myelodysplastic Syndrome, Leukemia, Myelodysplastic Syndrome, News


January 21st, 2008

Updates in the Management of Myelodysplastic Syndromes

By

Updates in the Management of Myelodysplastic Syndromes: A Report from the 2007 American Society of Hematology (ASH) Meeting IntroductionCytopenias – The Double-Edged SwordHypomethylating Agents – Living the Good LifeImmunomodulatory Agents Extend Their ApplicabilityConclusions Introduction The myelodysplastic syndromes (MDS) are a collection of clonally-derived hematopoietic disorders typified by peripheral blood cytopenias, transfusion-dependency, and in a subset […]

View full entry

Tags: General Myelodysplastic Syndrome, Myelodysplastic Syndrome, News